1. Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers
- Author
-
Mendy M. Welsink-Karssies, Annet M. Bosch, Marc Engelen, Johanna H. van der Lee, Sacha Ferdinandusse, Mirian C. H. Janssen, Radka Saldova, Janneke G. Langendonk, Eileen P. Treacy, Carla E. M. Hollak, Stefan D. Roosendaal, Maaike de Vries, Gert J. Geurtsen, Fred M. Vaz, Hidde H. Huidekoper, Kim J. Oostrom, M. Estela Rubio-Gozalbo, Roisin O'Flaherty, RS: GROW - R4 - Reproductive and Perinatal Medicine, Kindergeneeskunde, MUMC+: MA Medische Staf Kindergeneeskunde (9), Pediatrics, Internal Medicine, Graduate School, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory Genetic Metabolic Diseases, Medical Psychology, ANS - Neurodegeneration, APH - Mental Health, Endocrinology, General Paediatrics, APH - Methodology, APH - Quality of Care, Child and Adolescent Psychiatry & Psychosocial Care, APH - Personalized Medicine, ARD - Amsterdam Reproduction and Development, Radiology and Nuclear Medicine, Medical Microbiology and Infection Prevention, Neurology, Paediatric Neurology, ANS - Cellular & Molecular Mechanisms, and Paediatric Metabolic Diseases
- Subjects
GALT deficiency ,Pediatrics ,medicine.medical_specialty ,igg n-glycosylation ,Movement disorders ,clinical outcome ,CHILDREN ,prognostic biomarkers ,03 medical and health sciences ,0302 clinical medicine ,MANAGEMENT ,medicine ,Outpatient clinic ,030304 developmental biology ,glycan ,0303 health sciences ,Newborn screening ,medicine.diagnostic_test ,business.industry ,Galactosemia ,General Engineering ,Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6] ,Magnetic resonance imaging ,Guideline ,medicine.disease ,verbal dyspraxia ,Natural history ,classical galactosemia ,Cohort ,Original Article ,medicine.symptom ,business ,030217 neurology & neurosurgery ,MRI - Abstract
Early diagnosis and dietary treatment do not prevent long-term complications, which mostly affect the central nervous system in classical galactosemia patients. The clinical outcome of patients is highly variable, and there is an urgent need for prognostic biomarkers. The aim of this study was first to increase knowledge on the natural history of classical galactosemia by studying a cohort of patients with varying geno- and phenotypes and second to study the association between clinical outcomes and two possible prognostic biomarkers. In addition, the association between abnormalities on brain MRI and clinical outcomes was investigated. Classical galactosemia patients visiting the galactosemia expertise outpatient clinic of the Amsterdam University Medical Centre were evaluated according to the International Classical Galactosemia guideline with the addition of an examination by a neurologist, serum immunoglobulin G N-glycan profiling and a brain MRI. The biomarkers of interest were galactose-1-phosphate levels and N-glycan profiles, and the clinical outcomes studied were intellectual outcome and the presence or absence of movement disorders and/or primary ovarian insufficiency. Data of 56 classical galactosemia patients are reported. The intellectual outcome ranged from 45 to 103 (mean 77 ± 14) and was, Patients with classical galactosemia frequently suffer from complications affecting the brain for which prognostic factors are lacking. In our cohort of classical galactosemia patients, we demonstrated a highly variable outcome, distinguished a subgroup of milder ‘variant patients’ and found an association between MRI abnormalities and lower intellectual outcomes and movement disorders., Graphical Abstract Graphical Abstract
- Published
- 2020
- Full Text
- View/download PDF